$650,000 of BOOZ ALLEN HAMILTON INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"- H.R. 3838 / S. 2296 FY26 National Defense Authorization Act, all provisions related to Cybersecurity, Acquisition, and Missile Defense. - Emerging Technologies - Intelligence Authorization Act, 2026, all provisions related to: Cybersecurity - Cybersecurity - IRS Modernization - FAA Modernization - Artificial Intelligence - Quantum - Cyber - H.R. 4016/ S. ## FY26 Defense Appropriations, all provisions related to Missile Defense - H.R. 1 Reconciliation Bill, all provisions related to Missile Defense - Issues related to Health IT Modernization"
You can find more data on corporate lobbying on Quiver Quantitative.
BAH Hedge Fund Activity
We have seen 346 institutional investors add shares of BAH stock to their portfolio, and 479 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,296,316 shares (+inf%) to their portfolio in Q2 2025, for an estimated $239,115,385
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,447,160 shares (-20.5%) from their portfolio in Q2 2025, for an estimated $150,692,770
- PRIMECAP MANAGEMENT CO/CA/ added 1,207,058 shares (+2011.8%) to their portfolio in Q2 2025, for an estimated $125,690,949
- JPMORGAN CHASE & CO removed 1,120,283 shares (-45.0%) from their portfolio in Q2 2025, for an estimated $116,655,068
- JANUS HENDERSON GROUP PLC removed 1,081,675 shares (-44.5%) from their portfolio in Q2 2025, for an estimated $112,634,817
- MAN GROUP PLC removed 1,067,599 shares (-74.5%) from their portfolio in Q2 2025, for an estimated $111,169,083
- TWO SIGMA INVESTMENTS, LP removed 1,044,793 shares (-88.1%) from their portfolio in Q2 2025, for an estimated $108,794,295
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BAH Analyst Ratings
Wall Street analysts have issued reports on $BAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 07/28/2025
- William Blair issued a "Outperform" rating on 07/22/2025
- Goldman Sachs issued a "Sell" rating on 05/28/2025
- Wells Fargo issued a "Overweight" rating on 05/27/2025
To track analyst ratings and price targets for BAH, check out Quiver Quantitative's $BAH forecast page.
BAH Price Targets
Multiple analysts have issued price targets for $BAH recently. We have seen 7 analysts offer price targets for $BAH in the last 6 months, with a median target of $119.0.
Here are some recent targets:
- Jonathan Siegmann from Stifel set a target price of $119.0 on 07/28/2025
- Seth Seifman from JP Morgan set a target price of $122.0 on 07/28/2025
- Gavin Parsons from UBS set a target price of $119.0 on 07/28/2025
- Noah Poponak from Goldman Sachs set a target price of $94.0 on 05/28/2025
- David Strauss from Barclays set a target price of $120.0 on 05/28/2025
- Matthew Akers from Wells Fargo set a target price of $135.0 on 05/27/2025
- Tobey Sommer from Truist Securities set a target price of $110.0 on 04/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
